JPMorgan analyst Arun Jayaram raised the firm’s price target on Ovintiv to $52 from $51 and keeps an Overweight rating on the shares. The firm expects an operational beat in Q3 from Ovintiv on the back of “upbeat” operational performance on the field. However, after marking to market its estimates for strip pricing, JPMorgan expects a cash flow and EBITDAX miss in the quarter.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OVV:
- Ovintiv price target lowered to $53 from $60 at Barclays
- Ovintiv 3% higher after Street Insider report on takeover rumor
- Ovintiv price target lowered to $42 from $51 at Wells Fargo
- Ovintiv price target lowered to $54 from $60 at Evercore ISI
- Ovintiv price target lowered to $47 from $62 at Truist